Thrombelastography rotational (ROTEM®) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with rFVIIa (NOVOSEVEN®)

被引：0
|
作者：
Garcia-Rodriguez, M. [1 ]
Alvarez, M. [1 ]
Martin-Salces, M. [1 ]
Fernandez, I [1 ]
Butta, N. [1 ]
Rivas, I [1 ]
Munoz, I [1 ]
Jimenez-Yuste, V [1 ]
Hernandez-Navarro, F. [1 ]
机构：
[1] Hosp La Paz, Hematol, Madrid, Spain
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-604
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [1] Thrombelastography rotational (ROTEM®) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with FEIBA®
    Garcia-Rodriguez, M.
    Martin-Salces, M.
    Alvarez, M.
    Fernandez, I
    Butta, N.
    Munoz, I
    Rivas, I
    Jimenez-Yuste, V
    Hernandez-Navarro, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1135 - 1135
  • [2] Thrombelastography rotational (ROTEM®) utility for monitoring treatment in a patient with acquired haemophilia
    Garcia-Rodriguez, M.
    Alvarez, M.
    Martin-Salces, M.
    Fernandez, I
    Butta, N.
    Munoz, I
    Rivas, I
    Jimenez-Yuste, V
    Hernandez-Navarro, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1195 - 1195
  • [3] Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX
    Valentino, L. A.
    Cooper, D. L.
    Goldstein, B.
    HAEMOPHILIA, 2011, 17 (04) : 579 - 589
  • [4] Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven®) therapy in haemophilia a patients
    Viuff, Dorthe
    Andersen, Soren
    Sorensen, Brit B.
    Lethagen, Stefan
    THROMBOSIS RESEARCH, 2010, 126 (02) : 144 - 149
  • [5] Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery
    Shapiro, AD
    Gilchrist, GS
    Hoots, WK
    Cooper, HA
    Gastineau, DA
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (05) : 773 - 778
  • [6] Factor VIII inhibitors in haemophilia A patients who are considered as previously treated patients
    von Auer, C
    Oldenburg, J
    Krause, M
    Miesbach, W
    Scharrer, I
    BLOOD, 2005, 106 (11) : 107B - 107B
  • [7] Pathophysiology of inhibitors to factor VIII in patients with haemophilia A
    Lacroix-Desmazes, S
    Misra, N
    Bayry, J
    Artaud, C
    Drayton, B
    Kaveri, SV
    Kazatchkine, MD
    HAEMOPHILIA, 2002, 8 (03) : 273 - 279
  • [8] The economic impact of factor VIII inhibitors in patients with haemophilia
    Bohn, RL
    Aledort, LM
    Putnam, KG
    Ewenstein, BM
    Mogun, H
    Avorn, J
    HAEMOPHILIA, 2004, 10 (01) : 63 - 68
  • [9] Factor VIII inhibitors in patients with moderate severity haemophilia A
    Hay, CRM
    Ludlam, CA
    Colvin, BT
    Hill, FGH
    Preston, FE
    Bunschotten, EP
    Finvandraat, K
    Sultan, Y
    White, G
    Kasper, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 229 - 229
  • [10] ITER study of patients with haemophilia A and factor VIII inhibitors
    Holstein, K.
    Klamroth, R.
    von Depka, M.
    Gringeri, A.
    Lambert, T.
    Lopez-Fernandez, M.
    Diniz, M. J.
    Rocino, A.
    HAMOSTASEOLOGIE, 2010, 30 (4A): : S46 - S47
12345